Testing effectiveness (Phase 2)Study completedNCT02999295
What this trial is testing
Ramucirumab Plus Nivolumab in Participants With Gastric or GEJ Cancer
Who this might be right for
Gastric CancerGastroesophageal Junction Region (GEJ) Cancer
National Cancer Center, Japan 46